Rajpal Sharad, Gordon Debra B, Pellino Teresa A, Strayer Andrea L, Brost Denise, Trost Gregory R, Zdeblick Thomas A, Resnick Daniel K
Department of Neurosurgery, University of Wisconsin Hospital & Clinics, Madison, WI 5379, USA.
J Spinal Disord Tech. 2010 Apr;23(2):139-45. doi: 10.1097/BSD.0b013e3181cf07ee.
A preintervention and postintervention design was used to examine a total of 200 patients.
After successful implementation at our institution of a perioperative oral multimodal analgesia protocol in major joint arthroplasty, a modified regimen was provided to patients undergoing spine procedures.
A proactive, multimodal approach is currently recommended for the management of acute postoperative pain. Inadequate postoperative analgesia can negatively influence surgical outcome and duration of rehabilitation. Routine use of intravenous patient controlled analgesia (IV PCA) after surgery can result in substantial functional interference, side effects, and lead to untoward events as a result of programming errors.
A preintervention and postintervention design was used to compare a historical control group of spine surgery patients who received conventional IV PCA (N=100) with a prospective group who received some form of perioperative oral multimodal analgesia (N=100). The new regimen included preoperative and postoperative scheduled extended-release oxycodone, gabapentin, and acetaminophen, intraoperative dolasetron and as-needed postoperative short-acting oral oxycodone. Patient surveys and chart audits were used to measure pain intensity, functional interference from pain, opioid consumption, analgesic-related side effects, and patient satisfaction over the first 24 hours postoperatively.
Patients who received the new perioperative multimodal oral regimen had significantly less opioid consumption (P<0.001), lower ratings of Least Pain (P<0.01), and experienced less nausea (P<.001), drowsiness (P<0.05), interference with walking (P=0.05), and coughing and deep breathing (P<0.05) compared with the IV PCA group.
This quality improvement study shows some safety and significant advantages of a multimodal perioperative oral analgesic regimen compared with standard IV PCA after spine surgery.
采用干预前和干预后设计对总共200例患者进行研究。
在我们机构成功实施主要关节置换术围手术期口服多模式镇痛方案后,为接受脊柱手术的患者提供了一种改良方案。
目前推荐采用积极的多模式方法来管理急性术后疼痛。术后镇痛不足会对手术结果和康复时间产生负面影响。术后常规使用静脉自控镇痛(IV PCA)可能会导致严重的功能干扰、副作用,并因编程错误引发不良事件。
采用干预前和干预后设计,将接受传统IV PCA的脊柱手术患者历史对照组(N = 100)与接受某种形式围手术期口服多模式镇痛的前瞻性组(N = 100)进行比较。新方案包括术前和术后定时服用缓释羟考酮、加巴喷丁和对乙酰氨基酚,术中使用多拉司琼,术后按需服用短效口服羟考酮。通过患者调查和病历审核来测量术后头24小时内的疼痛强度、疼痛引起的功能干扰、阿片类药物消耗量、镇痛相关副作用以及患者满意度。
与IV PCA组相比,接受新围手术期多模式口服方案的患者阿片类药物消耗量显著减少(P < 0.001),最低疼痛评分更低(P < 0.01),恶心(P < 0.001)、嗜睡(P < 0.05)、行走干扰(P = 0.05)以及咳嗽和深呼吸干扰(P < 0.05)的发生率更低。
这项质量改进研究表明,与脊柱手术后标准IV PCA相比,围手术期口服多模式镇痛方案具有一定安全性和显著优势。